Upper Road
An Industry Leader
Upper Road is on the forefront of oncology research leveraging the power of AI to provide cancer patients with the most promising treatment options. The core of our innovative approach is our proprietary AI platform, Upper OI (oncolytic intelligence), which leverages the power of artificial intelligence to analyze a vast array of data points, including genetic, molecular, and clinical information, to identify the most promising clinical trials for individual cancer patients.
Our mission is grounded in the belief that personalized medicine is the future of cancer treatment. Every patient's cancer is unique, and thus, the treatments must be equally tailored. Our technology not only helps in identifying the right trials but also accelerates the timeline significantly, which is crucial given the time-sensitive nature of cancer treatment.
Upper Road's approach not only benefits patients by providing access to cutting-edge treatments but also aids researchers and doctors in recruiting suitable candidates for their trials, thereby accelerating the development of new cancer therapies. Founded in 2022, Upper Road brings together an incredible team of engineers and clinical oncologists committed to ongoing development and improvement of our AI algorithms to stay at the forefront of the fight against cancer.
​
 |  |
|---|
Our Technology
Advanced Solutions for Clinical Oncologists and Patients
Patient-focused solutions are at the core of all that we do at Upper Road. Our goal is to create smart and timely tools using AI technology that will provide patients with the best path forward in their battle against cancer. Click below to learn more about the technology behind our Upper OI tools, or get in touch to set up a meeting with one of our team members.